Lipoprotein(a), apolipoprotein(a) polymorphism and coronary atherosclerosis severity in type 2 diabetic patients

This publication has 24 references indexed in Scilit:

• Apolipoprotein(a) Size and Lipoprotein(a) Concentration and Future Risk of Angina Pectoris with Evidence of Severe Coronary Atherosclerosis in Men: The Physicians’ Health Study
  Clinical Chemistry, 2004
• 2003 European Society of Hypertension???European Society of Cardiology guidelines for the management of arterial hypertension*
  Journal Of Hypertension, 2003
• Assessment of Asymptomatic Coronary Artery Disease in Apparently Uncomplicated Type 2 Diabetic Patients
  Diabetes Care, 2002
• Lipoprotein(a) and Coronary Heart Disease
  Circulation, 2000
• Apolipoprotein(a) size and pentanucleotide repeat polymorphisms are associated with the degree of atherosclerosis in coronary heart disease
  Atherosclerosis, 1996
• Apolipoprotein(a) Kringle IV Repeat Number Predicts Risk for Coronary Heart Disease
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1996
• Rapid Angiographic Progression of Coronary Artery Disease in Patients With Elevated Lipoprotein(a)
  Circulation, 1995
• Independent Correlation Between Plasma Lipoprotein(a) and Angiographie Coronary Artery Disease in NIDDM
  Diabetes Care, 1995
• Plasma Lp(a) levels correlate with number, severity, and length-extension of coronary lesions in male patients undergoing coronary arteriography for clinically suspected coronary atherosclerosis.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
• Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.
  Circulation, 1986